Frequently asked questions

Why does LivaNova present research findings at medical congresses?

Presenting at congresses allows LivaNova to share emerging and new clinical evidence with healthcare professionals, fostering transparency and trust in our therapies. It demonstrates our commitment to advancing science and improving patient outcomes.

How do congress presentations benefit healthcare professionals?

Congress presentations provide clinicians with peer-reviewed data and real-world evidence, helping them make informed decisions about treatment options. This exchange of knowledge supports best practices and enhances patient care.

Why are congress presentations important for regulatory and market access?

Congress presentations often highlight pivotal trial results and post-market studies, which can support regulatory submissions and reimbursement discussions.

How do congress presentations drive innovation at LivaNova?

Engaging with global experts at congresses sparks collaboration and feedback that inform future research and product development. This dialogue accelerates innovation and ensures our solutions meet evolving clinical needs.

What role do congress presentations play in patient care?

Ultimately, sharing research findings at congresses helps translate evidence into practice. When clinicians understand the latest data, they can use it to improve patient outcomes, aligning with the mission of LivaNova to enhance lives through advanced therapies.

How do congress presentations support broader adoption of LivaNova therapies?

Congress presentations showcase real-world evidence and clinical trial results to a global audience of healthcare professionals. This visibility can help clinicians understand the value and effectiveness of our therapies, encouraging confidence in their use and ultimately driving wider adoption in clinical practice.